Telniz CT 40/6.25 Tablet is primarily used to manage high blood pressure, also referred to as hypertension. This medication belongs to the class of antihypertensives.
Telniz CT 40/6.25 Tablet is indicated for:
• Management of high blood pressure (hypertension)
• Reduction of risk for heart attacks
• Lowering the chances of strokes
• Take the tablet whole with a glass of water.
• Avoid crushing or chewing the tablet.
• This medicine should be taken at the same time each day.
• It can be taken with or without food.
• Consult your doctor for any dosage adjustments or before discontinuing use.
Telniz CT 40/6.25 Tablet is taken orally.
Possible side effects of Telniz CT 40/6.25 Tablet include:
• Dizziness
• Nausea
• Diarrhoea
• Headache
• Back pain
Telniz CT 40/6.25 Tablet contains two active ingredients:
• Telmisartan (40 mg): An angiotensin receptor blocker (ARB) that relaxes blood vessels, making it easier for the heart to pump blood, thereby reducing blood pressure.
• Chlorthalidone (6.25 mg): A diuretic that facilitates the elimination of surplus water and salts from the body through urine, thus reducing blood volume and lowering blood pressure.
Discontinue as soon as pregnancy is detected, as it may harm the foetus. Consult your doctor for safer alternatives.
Avoid using Telniz CT 40/6.25 Tablet while breastfeeding. Discuss with your doctor for suitable options.
Avoid alcohol intake as it may exacerbate the blood pressure-lowering effects and induce side effects.
Exercise caution if you have mild to moderate liver impairment. This medicine is contraindicated in severe liver conditions.
Those with a history of kidney issues should consult their doctor before use.
This medicine may cause dizziness, affecting your ability to drive or operate machinery.
Contraindicated in cases of hypersensitivity to telmisartan, chlorthalidone, or any components of the tablet.
Not recommended for individuals under 18 years of age.
Use under medical supervision due to increased susceptibility to side effects.
Drug-Drug Interactions
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): May reduce the effectiveness of Telniz CT 40/6.25 Tablet in lowering blood pressure.
• Antihypertensive Medicines: Concurrent use may increase the risk of hypotension.
• Lithium-based Medications: May increase lithium levels, leading to toxicity.
Drug-Disease Interactions
• Diabetes: May impact blood sugar regulation, necessitating close monitoring.
• Electrolyte Imbalance: Use cautiously in patients with electrolyte imbalances due to potential effects.
Daily Dosage
• Take as advised by your doctor, adhering to the prescribed dosage. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.
Missed Dose
• If you miss a dose, take it as soon as you remember.
• If it is nearly time for your next dose, skip the missed dose and continue with your regular schedule.
• Do not double the dose.
Overdose
• Symptoms of overdose may include dizziness and nausea. Seek immediate medical attention if an overdose is suspected.
• Store at room temperature, ideally below 30°C.
• Keep in a dry place away from direct sunlight and moisture.
• Keep out of reach of children.
• Use before the expiry date for optimal effectiveness.
• Limit salt intake: As high salt consumption can increase blood pressure, countering the medicine's effectiveness.
• Stay hydrated: Given the diuretic effect leading to increased urination, ensure adequate fluid intake to prevent dehydration.
.avif)
%20(1).png)
.webp)